SCHEMBL22926327

SCHEMBL22926327

CCN(CC)C(=O)c1ccc(-c2ccc3ccccc3n2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.59
ALDH1A1 P00352 6/20 0.59
MAPT P10636 2/20 0.59
LMNA P02545 1/20 0.56
AR P10275 2/20 0.53
GAA P10253 1/20 0.51
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
KDM4E B2RXH2 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
MKNK1 Q9BUB5 1/20 0.48
MKNK2 Q9HBH9 1/20 0.48
CYP3A4 P08684 2/20 0.48
GMNN O75496 1/20 0.48
TP53 P04637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16099428 0.79 AR (0.62) HPGDALDH1A1MAPTLMNAAR
SCHEMBL28609425 0.78 RAB9A (0.55) HPGDALDH1A1MAPTARGAA
SCHEMBL6973873 0.76 ALDH1A1 (0.51) HPGDALDH1A1MAPTLMNAL3MBTL1
SCHEMBL19051437 0.76 NPC1 (0.62) HPGDALDH1A1MAPTARGAA
SCHEMBL18573223 0.76 AR (0.62) HPGDALDH1A1MAPTLMNAAR
SCHEMBL29044143 0.76 MEN1 (0.66) HPGDALDH1A1MAPTLMNAGAA
SCHEMBL26613499 0.75 ALDH1A1 (0.60) HPGDALDH1A1MAPTLMNAAR
SCHEMBL27924669 0.75 ALDH1A1 (0.58) HPGDALDH1A1MAPTARGAA
SCHEMBL4444933 0.75 HPGD (1.00) HPGDALDH1A1MAPTLMNAGAA
SCHEMBL28869317 0.75 RAB9A (0.56) HPGDALDH1A1MAPTARGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3587406-B1 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER FORMA THERAPEUTICS INC (US) 2021-01-27 EP disclosed